EUVIMEDEUVIMED entdecken
KorrekturQualitative StudieOpen Access · CC BY 4.0

Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study

The Oncologist · 05.11.2026 · 31 (12)

DOI: 10.1093/oncolo/oyag442 ↗

Kurz gefasst

Korrektur in der Zeitschrift The Oncologist, online erschienen am 13.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study. The Oncologist, 31(12). https://doi.org/10.1093/oncolo/oyag442

Vancouver

Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study. The Oncologist. 2026;31(12). doi:10.1093/oncolo/oyag442

BibTeX
@article{euvimed2026,
  title = {Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {12},
  doi = {10.1093/oncolo/oyag442}
}
Kostenlos starten →